Exposure to hazardous drugs: time to reevaluate your program?
Harrison
B R
BR
D000970:Antineoplastic Agents / Q000009:adverse effects*; D015386:Hazardous Substances / Q000009:adverse effects*; D006801:Humans; D016273:Occupational Exposure / Q000517:prevention & control*; D010593:Pharmaceutical Services / Q000592:standards*; D017751:Safety Management; D014481:United States
D000970:Antineoplastic Agents; D015386:Hazardous Substances